Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products

Forensic Toxicology

Volumn 33, Issue 1, 2015, Pages 112-121

  Hasegawa, Koutaro ^a   Wurita, Amin ^a   Minakata, Kayoko ^a   Gonmori, Kunio ^a   Yamagishi, Itaru ^a   Nozawa, Hideki ^a   Watanabe, Kanako ^a   Suzuki, Osamu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 Fluoro ADB; Adipose tissue; Herbal blend products; Methyl (R) 2 1 (5 fluoropentyl) 1H indazole 3 carboxamido 3,3 dimethylbutanoate; Postmortem distribution; Synthetic cannabinoid

Indexed keywords

BIPERIDEN; CANNABINOID; LEVOMEPROMAZINE; METHYL 2 [1 (5 FLUOROPENTYL) 1H INDAZOLE 3 CARBOXAMIDO] 3,3 DIMETHYLBUTANOATE; OLANZAPINE; QUETIAPINE; TROXIPIDE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ALCOHOL BLOOD LEVEL; ARTICLE; ASPHYXIA; AUTOPSY; BLOOD ANALYSIS; BRAIN TISSUE; CADAVER; CASE REPORT; CAUSE OF DEATH; CONSCIOUSNESS LEVEL; DRUG ABUSE; FEMORAL VEIN; HEART MUSCLE; HUMAN; HUMAN TISSUE; JAPAN; KIDNEY PARENCHYMA; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIVER; LIVOR MORTIS; LUNG CONGESTION; LUNG PARENCHYMA; MALE; PANCREAS; PETECHIA; PRESCRIPTION; PRIORITY JOURNAL; SKELETAL MUSCLE; SMOKING; SPLEEN; STOMACH CONTENT; TANDEM MASS SPECTROMETRY; TOXIC INHALATION; URINALYSIS; VOMITING;

EID: 84925493207     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-014-0259-0     Document Type: Article

References (17)

1. Zuba D, Byrska B (2013) Analysis of the prevalence and coexistence of synthetic cannabinoids in “herbal high” products in Poland. Forensic Toxicol 31:21–30
2. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y (2013) Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012. Forensic Toxicol 31:44–53
3. Chung H, Choi H, Heo S, Kim E, Lee J (2014) Synthetic cannabinoids abused in South Korea: drug identification by the National Forensic Service from 2009 to June 2013. Forensic Toxicol 32:82–88
4. Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (2014) Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products. Forensic Toxicol 32:105–115
5. Uchiyama N, Shimokawa Y, Kawamura M, Kikura-Hanajiri R, Hakamatsuka T (2014) Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol 32:266–281
6. Namera A, Urabe S, Saito T, Torikoshi-Hatano A, Shiraishi H, Arima Y, Nagao M (2013) A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair. Forensic Toxicol 31:338–343
7. Namera A, Konuma K, Kawamura M, Saito T, Nakamoto A, Yahata M, Ohta S, Miyazaki S, Shiraishi H, Nagao M (2014) Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human. Forensic Toxicol 32:68–74
8. Hasegawa K, Suzuki O, Wurita A, Minakata K, Yamagishi I, Nozawa H, Gonmori K, Watanabe K (2014) Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC–MS–MS with the standard addition method. Forensic Toxicol 32:225–234
9. Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Suzuki O, Watanabe K (2014) Identification and quantitation of a new cathinone designer drug PV9 in an “aroma liquid” product, antemortem whole blood and urine specimens, and a postmortem whole blood specimen in its fatal poisoning case. Forensic Toxicol 32:243–250
10. Saito T, Namera A, Miura N, Ohta S, Miyazaki S, Osawa M, Inokuchi S (2013) A fatal case of MAM-2201 poisoning. Forensic Toxicol 31:333–337
11. Sasaki C, Saito T, Shinozuka T, Irie W, Murakami C, Maeda K, Nakamaru N, Oishi M, Nakamura S, Kurihara K (2014) A case of death caused by abuse of a synthetic cannabinoid N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide. Forensic Toxicol. doi:10.1007/s11419-014-0246-5
12. Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Watanabe K, Suzuki O (2014) Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of the adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol. doi:10.1007/s11419-014-0245-6
13. Kudo K, Ishida T, Hikiji W, Hayashida M, Uekusa K, Usumoto Y, Tsuji A, Ikeda N (2009) Construction of calibration-locking databases for rapid and reliable drug screening by gas chromatography-mass spectrometry. Forensic Toxicol 27:21–31
14. Wurita A, Hasegawa K, Minakata K, Watanabe K, Suzuki O (2014) A large amount of new designer drug diphenidine coexisting with a synthetic cannabinoid 5-fluoro-AB-PINACA found in a dubious herbal product. Forensic Toxicol 32:331–337
15. Bonilla E (1978) Flameless atomic absorption spectrophotometric determination of manganese in rat brain and other tissues. Clin Chem 24:471–474
16. Wurita A, Suzuki O, Hasegawa K, Gonmori K, Minakata K, Yamagishi I, Nozawa H, Watanabe K (2013) Sensitive determination of ethylene glycol, propylene glycol and diethylene glycol in human whole blood by isotope dilution gas chromatography–mass spectrometry, and the presence of appreciable amounts of the glycols in blood of healthy subjects. Forensic Toxicol 31:272–280
17. Wurita A, Hasegawa K, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Suzuki O, Watanabe K (2014) Postmortem distribution of α-pyrrolidinobutiophenone in body fluids and solid tissues of a human cadaver. Legal Med 16:241–246